Anne Pumfery

1.6k total citations
26 papers, 1.3k citations indexed

About

Anne Pumfery is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Anne Pumfery has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Virology and 8 papers in Immunology. Recurrent topics in Anne Pumfery's work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (6 papers) and T-cell and Retrovirus Studies (5 papers). Anne Pumfery is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (6 papers) and T-cell and Retrovirus Studies (5 papers). Anne Pumfery collaborates with scholars based in United States, Australia and France. Anne Pumfery's co-authors include Fatah Kashanchi, Longwen Deng, Cynthia de la Fuente, Emmanuel Agbottah, Kylene Kehn‐Hall, John Brady, Anil Maddukuri, Reem Berro, Sergeï Nekhai and Curtis R. Brandt and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Journal of Virology.

In The Last Decade

Anne Pumfery

26 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anne Pumfery

Since Specialization

Citations

This map shows the geographic impact of Anne Pumfery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Pumfery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Pumfery more than expected).

Fields of papers citing papers by Anne Pumfery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Pumfery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Pumfery. The network helps show where Anne Pumfery may publish in the future.

Co-authorship network of co-authors of Anne Pumfery

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Pumfery. A scholar is included among the top collaborators of Anne Pumfery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Pumfery. Anne Pumfery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identifying the Membrane Proteome of HIV-1 Latently Infected Cells 2007 ·Journal of Biological Chemistry ·Reem Berro, Cynthia de la Fuente, Zachary Klase, Kylene Kehn‐Hall, (unknown), Anne Pumfery, Emmanuel Agbottah, Ákos Vértes, Sergeï Nekhai, Fatah Kashanchi	51
2	Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor-α, CH11 and CYC202 2007 ·Endocrine Related Cancer ·(unknown), (unknown), Mark Bloomston, (unknown), Fu‐Sheng Chou, Theodore S. Glickman, Timothy A. McCaffrey, (unknown), Anne Pumfery, Daniel Lee, Matthew D. Ringel, Joseph J. Pinzone	29
3	Involvement of HTLV-I Tax and CREB in aneuploidy: a bioinformatics approach 2006 ·Retrovirology ·Cynthia de la Fuente, (unknown), Zachary Klase, Katharine Strouss, Patrick Cahan, (unknown), (unknown), Patricia Soteropoulos, Anne Pumfery, Masahiro Fujii, Fatah Kashanchi	16
4	Potential Use of Pharmacological Cyclin-Dependent Kinase Inhibitors as Anti-HIV Therapeutics 2006 ·Current Pharmaceutical Design ·Anne Pumfery, Cynthia de la Fuente, Reem Berro, Sergeï Nekhai, Fatah Kashanchi, Sheng‐Hao Chao	39
5	Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription 2006 ·Retrovirology ·Emmanuel Agbottah, Longwen Deng, Luke O. Dannenberg, Anne Pumfery, Fatah Kashanchi	94
6	Inhibition of HIV-1 virus replication using small soluble Tat peptides 2005 ·Virology ·Emmanuel Agbottah, Naigong Zhang, (unknown), Anne Pumfery, John D. Wade, Chen Zeng, Fatah Kashanchi	28
7	Therapeutic targets for HIV-1 infection in the host proteome 2005 ·Retrovirology ·Winnie S. Liang, Anil Maddukuri, Tanya M. Teslovich, Cynthia de la Fuente, Emmanuel Agbottah, (unknown), Kylene Kehn‐Hall, Sampsa Hautaniemi, Anne Pumfery, Dietrich Stephan, Fatah Kashanchi	26
8	The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells 2004 ·Retrovirology ·Kylene Kehn‐Hall, Longwen Deng, Cynthia de la Fuente, Katharine Strouss, Kaili Wu, Anil Maddukuri, (unknown), Robyn Rufner, Anne Pumfery, María Elena Bottazzi, Fatah Kashanchi	43
9	Antiviral Activity of CYC202 in HIV-1-infected Cells 2004 ·Journal of Biological Chemistry ·Emmanuel Agbottah, Cynthia de la Fuente, (unknown), Anna Barnett, Athos Gianella-Borradori, Anne Pumfery, Fatah Kashanchi	58
10	Use of a multi-virus array for the study of human viral and retroviral pathogens: gene expression studies and ChIP-chip analysis 2004 ·Retrovirology ·Elodie Ghedin, Anne Pumfery, Cynthia de la Fuente, Karen Yao, Naomi Miller, Vincent Lacoste, John Quackenbush, Steven Jacobson, Fatah Kashanchi	12
11	The HTLV-I Tax oncoprotein targets the retinoblastoma protein for proteasomal degradation 2004 ·Oncogene ·Kylene Kehn‐Hall, Cynthia de la Fuente, Katharine Strouss, Reem Berro, Hua Jiang, John Brady, Renaud Mahieux, Anne Pumfery, María Elena Bottazzi, Fatah Kashanchi	85
12	Pharmacological Cyclin-Dependent Kinase Inhibitors as HIV-1 Antiviral Therapeutics 2003 ·Current HIV Research ·Cynthia de la Fuente, Anil Maddukuri, Kylene Kehn‐Hall, (unknown), Longwen Deng, Anne Pumfery, Fatah Kashanchi	26
13	Protein Profile of Tax-associated Complexes 2003 ·Journal of Biological Chemistry ·Kaili Wu, María Elena Bottazzi, Cynthia de la Fuente, Longwen Deng, Scott D. Gitlin, Anil Maddukuri, (unknown), Hong Li, Ákos Vértes, Anne Pumfery, Fatah Kashanchi	80
14	Chromatin Remodeling and Modification during HIV-1 Tat-activated Transcription 2003 ·Current HIV Research ·Anne Pumfery, Longwen Deng, Anil Maddukuri, (unknown), Hong Li, John D. Wade, Paul F. Lambert, Ajit Kumar, Fatah Kashanchi	66
15	HIV-1 Tat Interaction with RNA Polymerase II C-terminal Domain (CTD) and a Dynamic Association with CDK2 Induce CTD Phosphorylation and Transcription from HIV-1 Promoter 2002 ·Journal of Biological Chemistry ·Longwen Deng, Tatiana Ammosova, Anne Pumfery, Fatah Kashanchi, Sergeï Nekhai	76
16	Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signals 2002 ·BMC Biochemistry ·Cynthia de la Fuente, Francisco Santiago, Longwen Deng, (unknown), (unknown), Kylene Kehn‐Hall, Anil Maddukuri, (unknown), Kaili Wu, (unknown), Anne Pumfery, Fatah Kashanchi	73
17	Identification of Kaposin (ORF K12) as a Human Herpesvirus 8 (Kaposi's Sarcoma Associated Herpesvirus) Oncogene. 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Sumitra Muralidhar, Anne Pumfery, Morad Hassani, M. Reza Sadaie, Norio Azumi, John Brady, Peter G. Medveczky, Leonard J. Rosenthal	3
18	Renin mRNA is synthesized locally in rat ocular tissues 1994 ·Current Eye Research ·Curtis R. Brandt, Anne Pumfery, Bruce Micales, Colleen D. Bindley, Gary E. Lyons, Stephen J. Sramek, I. H. L. Wallow	32
19	Enhanced Inhibition of Herpes Simplex Virus Type 1 Growth in Human Corneal Fibroblasts by Combinations of Interferon- and - 1992 ·The Journal of Infectious Diseases ·(unknown), (unknown), Anne Pumfery, Curtis R. Brandt	24
20	The herpes simplex virus ribonucleotide reductase is required for ocular virulence 1991 ·Journal of General Virology ·Curtis R. Brandt, (unknown), Anne Pumfery, Robert J. Visalli, (unknown)	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact